title: Phacoemulsification with aspirated or retained Viscoat.
abstract: Endothelial cell counts, morphology, and 24-hour postoperative intraocular pressure (IOP) changes were measured in 55 consecutive patients (60 eyes) who had uncomplicated phacoemulsification and posterior chamber lens implantation with either aspirated (30 eyes) or retained (30 eyes) Viscoat (sodium chondroitin sulfate-sodium hyaluronate). The surgical technique was standardized in all cases. Endothelial cell loss was almost identical in the aspirated and in the retained groups (8.8% and 8.7%). Postoperative pleomorphism was significantly less in the retained Viscoat group than in the aspirated group, suggesting a possible protective effect of the retained viscoelastic. Corneal thickness increased significantly in the retained Viscoat group, but this was not significant clinically. The retained Viscoat group had more patients with a postoperative IOP greater than 30 mm Hg and a greater mean increase in postoperative IOP, although the difference between the groups was not significant. The IOP changes may have been caused by blockage of the trabecular meshwork by the retained Viscoat. The results suggest that Viscoat can be retained after cataract surgery if the surgeon is prepared for a greater 24-hour postoperative increase in IOP.
authors.affiliation: Department of Ophthalmology, University Hospital, University of Western Ontario, London, Canada.
authors.forename: L E
authors.initials: LE
authors.lastname: Probst
authors.forename: O J
authors.initials: OJ
authors.lastname: Hakim
authors.forename: B D
authors.initials: BD
authors.lastname: Nichols
mesh_terms: D000368:Aged; D002387:Cataract Extraction / Q000379:methods; D002452:Cell Count; D002807:Chondroitin / Q000009:adverse effects; D002809:Chondroitin Sulfates; D004322:Drainage; D004338:Drug Combinations; D004728:Endothelium, Corneal / Q000166:cytology; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects; D007429:Intraocular Pressure; D007910:Lenses, Intraocular; D008297:Male; D009798:Ocular Hypertension / Q000209:etiology
chemical_list: D004338:Drug Combinations; C501944:chondroitin sulfate, sodium hyaluronate drug combination; D006820:Hyaluronic Acid; D002807:Chondroitin; D002809:Chondroitin Sulfates